Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2007
03/28/2007CN1935128A Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone
03/28/2007CN1307296C Stress-relieving perfumes and stress-relieving perfume compsns. contg. same
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307178C Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
03/28/2007CN1307176C Novel alkoxypyridine-derivatives
03/28/2007CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/28/2007CN1307157C Novel compounds
03/28/2007CN1307150C Hydroxy tetrahydro-naphthalenylurea derivatives
03/28/2007CN1307147C 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
03/28/2007CN1306934C Pharmaceutical composition containing zaleplon and its preparation method
03/27/2007USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations
03/27/2007US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/27/2007US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007US7196199 Phenoxypropylamine compounds
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196096 Substituted amines of spirofuropyridines useful in therapy
03/27/2007US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents
03/27/2007US7196088 5-HT6 modulators; such as 2-benzenesulfonyl-5-piperazin-1-yl-1,2,3,4-tetrahydroisoquinoline;
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007US7196079 for treating, headache, migraine or cluster headache
03/27/2007US7196077 Tachykinin antagonists
03/27/2007US7196071 Methods of decreasing or preventing pain using spicamycin derivatives
03/27/2007US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders
03/27/2007US7195894 MKK7 activation inhibitor
03/27/2007US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
03/27/2007US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
03/27/2007US7195778 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
03/27/2007US7195761 Humanized antibodies that sequester abeta peptide
03/27/2007CA2399976C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
03/27/2007CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/27/2007CA2303810C Antistress agents and functional foods
03/27/2007CA2251820C Substituted benzylamines and their use for the treatment of depression
03/27/2007CA2180841C 1-aminoindan derivatives and compositions thereof
03/27/2007CA2179733C Anticonvulsant pseudofructopyranose sulfamates
03/27/2007CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives
03/26/2007CA2560798A1 Administering pharmaceutical compositions to the mammalian central nervous system
03/23/2007CA2631096A1 Piperidine and piperazine derivatives
03/22/2007WO2007033192A1 Salicylate and gentisate salts of a piperazine compound
03/22/2007WO2007033191A1 Glucuronate salt of a piperazine compound
03/22/2007WO2007032854A1 FUSED TRICYCLIC mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS
03/22/2007WO2007032833A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
03/22/2007WO2007032699A1 (+)-and-(-)-trans-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1h-pyrido[4,3-b] indole optical isomers
03/22/2007WO2007032572A1 N-substituted-1h-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same
03/22/2007WO2007032566A1 Hematopoietic stem cell proliferator
03/22/2007WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
03/22/2007WO2007032466A1 Heterocyclic compound, and production process and use thereof
03/22/2007WO2007032445A1 Protein kinase inhibitors
03/22/2007WO2007032396A1 Therapeutic agent for spinal cord injury
03/22/2007WO2007031977A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
03/22/2007WO2007031838A1 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
03/22/2007WO2007031828A2 Therapeutic pyrrolidines
03/22/2007WO2007031720A1 1,2-diarylimidazoles for use as cbi modulators
03/22/2007WO2007031284A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
03/22/2007WO2007030939A2 Methods of modulating neurotrophin-mediated activity
03/22/2007WO2007015004A3 Novel crystalline v form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form
03/22/2007WO2006134385A3 Anti-inflammatory agents
03/22/2007WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto
03/22/2007WO2006127574A3 Method for the treatment of noise phobia in companion animals
03/22/2007WO2006119884A3 Method for the treatment of drug abuse with flibanserin
03/22/2007WO2006119758A3 Dihydroxyphenylalanine derivatives
03/22/2007WO2006117609A3 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
03/22/2007WO2006113853A3 Topiramate compositions for treatment of headache
03/22/2007WO2006111983A3 NOVEL POLYMORPHIC FORM OF (l-BENZYL-4-[(5,6-DIMETHOXY-l- INDANONE)-2-YL]METHYL PIPERIDINE HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
03/22/2007WO2006106432A8 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders
03/22/2007WO2006086562A3 Phenylazetidinone derivatives
03/22/2007WO2006058781A3 Finasteride, dutasteride and related compounds for preventing/treating neurologically-associated disorders
03/22/2007WO2006030217A3 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
03/22/2007WO2005115548A3 Treating depressive disorders with carbonic anhydrase activators
03/22/2007WO2005072308A3 Cgrp receptor antagonists
03/22/2007US20070067861 Cloning pigs using donor nuclei from differentiated cells
03/22/2007US20070067856 Therapeutic agent for NGF
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066686 Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient
03/22/2007US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates
03/22/2007US20070066653 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/22/2007US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/22/2007US20070066640 Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/22/2007US20070066593 Use of carbamazepine derivatives for the treatment of agitation in dementia patients
03/22/2007US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/22/2007US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/22/2007US20070066554 Immunostimulatory nucleic acids
03/22/2007US20070066543 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity
03/22/2007US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/22/2007US20070066519 Use of human growth hormone in multiple system atrophy
03/22/2007US20070066440 Automatic transmission
03/22/2007US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
03/22/2007US20070065868 IL-17 receptor like molecules and uses thereof
03/22/2007US20070065517 Modafinil Pharmaceutical Compositions
03/22/2007US20070065493 External patch containing estrogen and/or progestogen
1 ... 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 ... 1833